Article
Future of Immunotherapy in Melanoma to Focus on Overcoming Resistance, Personalizing Regimens
Rating:
0.0
Views:
94
Likes:
1
Library:
1
With an estimated 5-year survival rate of 50% and an ongoing issue of resistance, next steps with immunotherapy in melanoma will focus on stratifying patients, personalizing therapy, and refining localized regimens.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value